Related content

New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?

By Esteve-Pastor María Asunción   Hernández-Romero Diana   Valdés Mariano   Marín Francisco  

Molecules, Vol. 21, Iss. 3, 2016-02 ,pp. : 284-284

MDPI

Access to resources Recommend Favorite

Antiplatelet Usage Impacts Clot Density in Acute Anterior Circulation Ischemic Stroke

By Pikija Slaven   Magdic Jozef   Lukic Anita   Schreiber Catharina   Mutzenbach Johannes Sebastian   McCoy Mark R.   Sellner Johann  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-08 ,pp. : 1382-1382

MDPI

Access to resources Recommend Favorite

Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy

By Rwibasira Rudinga Gamariel   Khan Ghulam Jilany   Kong Yi  

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-02 ,pp. : 573-573

MDPI

Access to resources Recommend Favorite

Differentiation Therapy of Acute Myeloid Leukemia

By Gocek Elzbieta   Marcinkowska Ewa  

Cancers, Vol. 3, Iss. 2, 2011-05 ,pp. : 2402-2420

MDPI

Access to resources Recommend Favorite

Utilizing Chinese Admission Records for MACE Prediction of Acute Coronary Syndrome

By Hu Danqing   Huang Zhengxing   Chan Tak-Ming   Dong Wei   Lu Xudong   Duan Huilong  

International Journal of Environmental Research and Public Health, Vol. 13, Iss. 9, 2016-09 ,pp. : 912-912

MDPI

Access to resources Recommend Favorite